Largest public petition of its kind calls on Prime Minister to end the social...
More than 150,000 members of the public and more than 50 health leaders are calling on Prime Minister Boris Johnson to take action now...
Community pharmacy and cancer prevention
Recent studies have started to involve community pharmacy in cancer prevention, treatment and support. Deborah Evans explores how this can be done. There are around...
Cancer Research UK and Hummingbird Bioscience partner to advance antibody drug
Cancer Research UK and Hummingbird Bioscience have announced a partnership to develop Hummingbird’s anti-HER3 antibody drug, HMBD-001, for the treatment of people with HER3...
Hunt’s legacy: Neglect NHS staff at your peril
As Jeremy Hunt learned this week, and throughout his career, politicians neglect NHS staff at their peril. Claudia Rubin discusses Hunt’s legacy and how...
NHS focus on cardiovascular disease
Sue Thomas explores how the NHS is prioritising cardiovascular disease. Cardiovascular disease (CVD), which covers a wide range of conditions, including coronary heart disease, heart...
NICE publishes new indicators for asthma and COPD
A new suite of indicators for asthma and COPD has been published by NICE which includes several potential new indicators for the Quality and...
Ipsen UK & Ireland Launches New Pre-filled Syringe for Somatuline® Autogel® (lanreotide)
UK patients and healthcare professionals involved in the re-design of pre-filled syringe to meet the needs and expectations of patients. The UK affiliate of Ipsen...
Psychological impact of head and neck cancers
Bristol-Myers Squibb (BMS), in partnership with patient groups The Swallows and the Mouth Cancer Foundation, have announced the results from a patient survey into...
RSPH sets out detail of Government Prevention Green Paper
The Royal Society for Public Health (RSPH) has welcomed the publication of the highly anticipated Government's Prevention Green Paper. The document sets out the...
Prevention Green Paper published – Advancing our health: prevention in the 2020s
The Cabinet Office and Department of Health and Social Care have published their Prevention Green Paper, Advancing our health: prevention in the 2020s. It...
Latest articles
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Poor diabetes control costs the NHS £3bn in avoidable treatment
New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...